首页> 外文期刊>Journal of Medicinal Chemistry >A Modular Synthetic Route Involving N-Aryl-2-nitrosoaniline Intermediates Leads to a New Series of 3-Substituted Halogenated Phenazine Antibacterial Agents
【24h】

A Modular Synthetic Route Involving N-Aryl-2-nitrosoaniline Intermediates Leads to a New Series of 3-Substituted Halogenated Phenazine Antibacterial Agents

机译:涉及N-芳基-2-亚硝基苯胺中间体的模块化合成途径导致新系列3-取代的卤代苯脲素抗菌剂

获取原文
获取原文并翻译 | 示例
           

摘要

Pathogenic bacteria demonstrate incredible abilities to evade conventional antibiotics through the development of resistance and formation of dormant, surface-attached biofilms. Therefore, agents that target and eradicate planktonic and biofilm bacteria are of significant interest. We explored a new series of halogenated phenazines (HP) through the use of N-aryl-2-nitrosoaniline synthetic intermediates that enabled functionalization of the 3-position of this scaffold. Several HPs demonstrated potent antibacterial and biofilm-killing activities (e.g., HP 29, against methicillin-resistant Staphylococcus aureus: MIC = 0.075 mu M; MBEC = 2.35 mu M), and transcriptional analysis revealed that HPs 3, 28, and 29 induce rapid iron starvation in MRSA biofilms. Several HPs demonstrated excellent activities against Mycobacterium tuberculosis (HP 34, MIC = 0.80 mu M against CDC1551). This work established new SAR insights, and HP 29 demonstrated efficacy in dorsal wound infection models in mice. Encouraged by these findings, we believe that HPs could lead to significant advances in the treatment of challenging infections.
机译:病原菌通过产生耐药性和形成休眠的、表面附着的生物膜,表现出不可思议的逃避常规抗生素的能力。因此,针对并根除浮游生物和生物膜细菌的药剂具有重要意义。我们通过使用N-芳基-2-亚硝基苯胺合成中间体探索了一系列新的卤代吩嗪(HP),使该支架的3位功能化。几个HPs表现出强大的抗菌和生物膜杀伤活性(例如,HP 29,抗耐甲氧西林金黄色葡萄球菌:MIC=0.075μM;MBEC=2.35μM),转录分析显示HPs 3、28和29在MRSA生物膜中诱导快速铁饥饿。几个HPs对结核分枝杆菌表现出优异的活性(HP34,对CDC1551的MIC=0.80μM)。这项工作建立了新的SAR洞察,HP 29在小鼠背部伤口感染模型中证明了有效性。受这些发现的鼓舞,我们相信HPs可以在治疗挑战性感染方面取得重大进展。

著录项

  • 来源
    《Journal of Medicinal Chemistry》 |2021年第11期|共21页
  • 作者单位

    Univ Florida Coll Pharm Ctr Nat Prod Drug Discovery &

    Dev CNPD3 Dept Med Chem Gainesville FL 32610 USA;

    Univ Florida Coll Dent Dept Oral Biol Gainesville FL 32610 USA;

    Univ Rochester Dept Microbiol &

    Immunol Rochester NY 14642 USA;

    Univ Florida Coll Pharm Ctr Nat Prod Drug Discovery &

    Dev CNPD3 Dept Med Chem Gainesville FL 32610 USA;

    Univ Cent Florida Coll Med Burnett Sch Biomed Sci Orlando FL 32827 USA;

    Univ Florida Coll Pharm Ctr Nat Prod Drug Discovery &

    Dev CNPD3 Dept Med Chem Gainesville FL 32610 USA;

    Univ Florida Coll Pharm Ctr Nat Prod Drug Discovery &

    Dev CNPD3 Dept Med Chem Gainesville FL 32610 USA;

    Univ Florida Coll Pharm Ctr Nat Prod Drug Discovery &

    Dev CNPD3 Dept Med Chem Gainesville FL 32610 USA;

    Univ Florida Coll Med Dept Mol Genet &

    Microbiol Gainesville FL 32610 USA;

    Univ Florida Coll Med Dept Mol Genet &

    Microbiol Gainesville FL 32610 USA;

    Univ Florida Coll Pharm Ctr Nat Prod Drug Discovery &

    Dev CNPD3 Dept Med Chem Gainesville FL 32610 USA;

    Univ Florida Coll Pharm Ctr Nat Prod Drug Discovery &

    Dev CNPD3 Dept Med Chem Gainesville FL 32610 USA;

    Univ Cent Florida Coll Med Burnett Sch Biomed Sci Orlando FL 32827 USA;

    Univ Rochester Dept Microbiol &

    Immunol Rochester NY 14642 USA;

    Univ Florida Coll Dent Dept Oral Biol Gainesville FL 32610 USA;

    Univ Florida Coll Pharm Ctr Nat Prod Drug Discovery &

    Dev CNPD3 Dept Med Chem Gainesville FL 32610 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号